137 related articles for article (PubMed ID: 23333739)
1. Oseltamivir inhibits both viral entry and release but enhances apoptosis of cells infected with influenza A H1N1.
Gao R; Du N; Liu D; Li Z; Zhu Y; Shu Y
Biochem Biophys Res Commun; 2013 Feb; 431(4):788-95. PubMed ID: 23333739
[TBL] [Abstract][Full Text] [Related]
2. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro.
Lin X; Zhou J; Zhang Y; Wu J; Zhang F; Li Z; Zhang Y; Bi S; Shu Y; Wang Y
Biochem Biophys Res Commun; 2009 Dec; 390(4):1305-8. PubMed ID: 19879239
[TBL] [Abstract][Full Text] [Related]
3. Germacrone inhibits early stages of influenza virus infection.
Liao Q; Qian Z; Liu R; An L; Chen X
Antiviral Res; 2013 Dec; 100(3):578-88. PubMed ID: 24095670
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of a synthesized shikonin ester against influenza A (H1N1) virus and insights into its mechanism.
Zhang Y; Han H; Qiu H; Lin H; Yu L; Zhu W; Qi J; Yang R; Pang Y; Wang X; Lu G; Yang Y
Biomed Pharmacother; 2017 Sep; 93():636-645. PubMed ID: 28688289
[TBL] [Abstract][Full Text] [Related]
6. Novel influenza A(H1N1) 2009 in vitro reassortant viruses with oseltamivir resistance.
Ottmann M; Duchamp MB; Casalegno JS; Frobert E; Moulès V; Ferraris O; Valette M; Escuret V; Lina B
Antivir Ther; 2010; 15(5):721-6. PubMed ID: 20710053
[TBL] [Abstract][Full Text] [Related]
7. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus.
Hsieh CF; Lo CW; Liu CH; Lin S; Yen HR; Lin TY; Horng JT
J Ethnopharmacol; 2012 Aug; 143(1):57-67. PubMed ID: 22710290
[TBL] [Abstract][Full Text] [Related]
8. Effects of TheraMax on influenza virus infections in cell culture and in mice.
Smee DF; Hurst BL; Wong MH
Antivir Chem Chemother; 2011 Jul; 21(6):231-7. PubMed ID: 21730370
[TBL] [Abstract][Full Text] [Related]
9. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
10. Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with Oseltamivir.
Gaisina IN; Peet NP; Cheng H; Li P; Du R; Cui Q; Furlong K; Manicassamy B; Caffrey M; Thatcher GRJ; Rong L
J Med Chem; 2020 Mar; 63(6):3120-3130. PubMed ID: 32069052
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulaton and attenuation of lethal influenza A virus infection by oral administration with KIOM-C.
Kim EH; Pascua PN; Song MS; Baek YH; Kwon HI; Park SJ; Lim GJ; Kim SM; Decano A; Lee KJ; Cho WK; Ma JY; Choi YK
Antiviral Res; 2013 Jun; 98(3):386-93. PubMed ID: 23588232
[TBL] [Abstract][Full Text] [Related]
12. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
[TBL] [Abstract][Full Text] [Related]
13. Mixtures of oseltamivir-sensitive and -resistant pandemic influenza A/H1N1/2009 viruses in immunocompromised hospitalized children.
Suhaila M; Tang JW; Lee HK; Lin C; Tambyah PA; Yap HK; Quak SH; Koay ES
Pediatr Infect Dis J; 2011 Jul; 30(7):625-7. PubMed ID: 21206398
[TBL] [Abstract][Full Text] [Related]
14. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
Renaud C; Kuypers J; Englund JA
J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
[TBL] [Abstract][Full Text] [Related]
15. [Antiviral activity of Ouyi antipyretic detoxicate soft capsule against influenza a virus H1N1 in vitro].
He F; Liu Q; Liu Y; Zhou J; Gao Z; Xiao H; Yang Z
Zhongguo Zhong Yao Za Zhi; 2011 Jul; 36(14):1993-6. PubMed ID: 22016975
[TBL] [Abstract][Full Text] [Related]
16. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
17. More resistance to oseltamivir (Tamiflu).
Med Lett Drugs Ther; 2009 Jan; 51(1304):5-6. PubMed ID: 19172138
[No Abstract] [Full Text] [Related]
18. Anti-influenza viral effects of honey in vitro: potent high activity of manuka honey.
Watanabe K; Rahmasari R; Matsunaga A; Haruyama T; Kobayashi N
Arch Med Res; 2014 Jul; 45(5):359-65. PubMed ID: 24880005
[TBL] [Abstract][Full Text] [Related]
19. Pomegranate (Punica granatum) purified polyphenol extract inhibits influenza virus and has a synergistic effect with oseltamivir.
Haidari M; Ali M; Ward Casscells S; Madjid M
Phytomedicine; 2009 Dec; 16(12):1127-36. PubMed ID: 19586764
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain.
Ledesma J; Vicente D; Pozo F; Cilla G; Castro SP; Fernández JS; Ruiz MP; Navarro JM; Galán JC; Fernández M; Reina J; Larrauri A; Cuevas MT; Casas I; Breña PP;
J Clin Virol; 2011 Jul; 51(3):205-8. PubMed ID: 21592854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
